US Bancorp
IBIO icon

US Bancorp’s iBio IBIO Stock Holding History

US Bancorp’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-134
Closed -$11K – 4204
2022
Q3 		$11K Hold
134
– – ﹤0.01% 3342
2022
Q2 		$18K Hold
134
– – ﹤0.01% 3109
2022
Q1 		$29K Buy
134
+86
+179% +$18K ﹤0.01% 2873
2021
Q4 		$13K Hold
48
– – ﹤0.01% 3321
2021
Q3 		$26K Hold
48
– – ﹤0.01% 2988
2021
Q2 		$36K Hold
48
– – ﹤0.01% 2829
2021
Q1 		$37K Hold
48
– – ﹤0.01% 2729
2020
Q4 		$25K Hold
48
– – ﹤0.01% 2816
2020
Q3 		$49K Buy
+48
New +$69.6K ﹤0.01% 2409

Other funds holding IBIO

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

US Bancorp's IBIO Position: Q4 2022 in Review

US Bancorp sold out of iBio (IBIO) in Q4 2022, closing a stake of 134 shares — an estimated $11K sold.

US Bancorp first reported a position in IBIO in Q3 2020 and held it in 9 quarters. The position peaked at $49K in Q3 2020. 36 funds tracked by Wall St. Rank hold IBIO as of Q4 2022.

  • US Bancorp reported no remaining iBio position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 134 iBio shares in Q4 2022, an estimated $11K.
  • US Bancorp first reported a position in iBio in Q3 2020 and held it in 9 quarters.
  • US Bancorp's iBio position peaked at $49K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held iBio as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.